Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

JSE/CCC stock hub

JSE/CCC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JSE/CCCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

259.3M

Johannesburg Stock Exchange

Market data

Price

Recent price action with selectable time range.

JSE/CCCJSE/CCC

—

Loading chart…

In the news

Latest news · JSE/CCC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-273.2

P25 n/aP50 n/aP75 n/a

ROIC-168.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JSE/CCC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

ZAR

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Africa
Country code	ZA
Enterprise value	ZAc 206.7M
Exchange	Johannesburg Stock Exchange
Financial currency	ZAR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ZAE000310397
Last refreshed	2026-05-10
Market cap	ZAc 259.3M
Price	ZAc 90
Price currency	ZAc
Sector	Healthcare
Sic	2834
Symbol	jse/CCC
Website	https://www.cilocybin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-84.33%
EV Earnings	-0.95x
EV/FCF	-179.69x
EV/Sales	28.98x
FCF yield	-0.44%
P/B ratio	2.59x
P/S ratio	36.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	5.13%
Gross Profit	ZAc 365,983
Gross Profit Growth	-92.42%
Gross Profit Growth Q	-27.77%
Gross Profit Growth3 Y	-29.94%
Net Income	ZAc -218.7M
Net Income Growth Years	0%
Pretax Margin	-3,081.98%
ROA	-164.5
ROCE	-214.4
ROE	-273.2
ROIC	-168.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-71.9%
EPS Growth Years	0
FCF Growth Q	108.42%
OCF Growth	-73.52%
OCF Growth Q	145.29%
OCF Growth3 Y	2.37%
Revenue Growth	-58.8x
Revenue Growth Q	14.18x
Revenue Growth Years	0x
Revenue Growth3 Y	88.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ZAc 0.08
Assets	ZAc 108.9M
Cash	ZAc 58.3M
Current Assets	ZAc 90.1M
Current Liabilities	ZAc 4.9M
Debt	ZAc 5.6M
Debt Equity	ZAc 0.06
Debt FCF	ZAc -4.89
Equity	ZAc 100.2M
Liabilities	ZAc 8.8M
Long Term Assets	ZAc 18.9M
Long Term Liabilities	ZAc 3.9M
Net Cash	ZAc 52.6M
Net Cash By Market Cap	ZAc 20.3
Net Cash Growth	-12.58%
Net Debt Equity	ZAc -0.53
Tangible Book Value	ZAc 100.2M
Tangible Book Value Per Share	ZAc 0.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.49
Net Working Capital	ZAc 28.7M
Quick ratio	14.84
Working Capital	ZAc 85.2M
Working Capital Turnover	ZAc 0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	19.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-71.88%
200-day SMA	254.3
50-day SMA	119.3
50-day SMA vs 200-day SMA	50under200
All Time High	1,000
All Time High Change	-91%
All Time High Date	2024-07-01
All Time Low	70
All Time Low Change	28.57%
All Time Low Date	2026-03-23
ATR	3.13
Beta1y	1.2
Beta2y	0.91
Ch YTD	-58.14
High	90
High52	690
High52 Date	2025-10-06
High52ch	-86.96%
Low	85
Low52	70
Low52 Date	2026-04-13
Low52ch	28.57%
Ma50ch	-24.53%
Price vs 200-day SMA	-64.61%
RSI	45.08
RSI Monthly	33.42
RSI Weekly	33.81
Sharpe ratio	0.02x
Sortino ratio	0.07
Total Return	19.08%
Tr YTD	-58.14
Tr1m	-10%
Tr1w	9.76%
Tr3m	-51.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ZAc -223.1M
Operating margin	-3,128.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	169,399,737%
Net Borrowing	-3,151,416
Shares Insiders	11.22%
Shares Out	288,088,772
Shares Qo Q	30.89%
Shares Yo Y	-19.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ZAc -1.2M
Average Volume	1,386.55x
Bv Per Share	0.35
CAPEX	ZAc -1.8M
Ch1m	-10
Ch1w	9.76
Ch1y	-71.88
Ch3m	-51.35
Ch6m	-70.97
Change	0%
Change From Open	5.88
Close	90
Days Gap	-5.56
Depreciation Amortization	247,153
Dollar Volume	54,450
Earnings Date	2026-02-20
EBIT	ZAc -223.1M
EBITDA	ZAc -222.9M
EPS	ZAc -3.34
F Score	3
FCF	ZAc -1.2M
FCF EV Yield	-0.56x
FCF Per Share	ZAc -0
Financing CF	-5,357,516
Fiscal Year End	March
Founded	2,018
Income Tax	ZAc -1.1M
Investing CF	-1,828,333
Is Primary Listing	1
Last Earnings Date	2026-02-20
Last Report Date	2025-09-30
Ma150	239.5
Ma150ch	-62.42%
Ma20	80
Ma20ch	12.5%
Net CF	-6,508,426
Open	85
P OCF Ratio	382.3
Position In Range	100
Ppne	14,355,375
Price Date	2026-05-07
Ptbv Ratio	2.59
Relative Volume	0.25x
Revenue	7,131,743x
Tax By Revenue	-16.04x
Tr6m	-70.97%
Volume	605
Z Score	8.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does JSE/CCC pay a dividend?

Capital-return profile for this ticker.

Performance

JSE/CCC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JSE/CCC?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+11.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-19.1%

Negative means the company is buying back shares.

Technical

JSE/CCC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.1

Neutral momentum band

Price vs 200-day MA

-64.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JSE/CCC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current jse/CCC stock rating?

jse/CCC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full jse/CCC analysis?

The full report lives at /stocks/jse/CCC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for jse/CCC?

The latest report frames jse/CCC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the jse/CCC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.